Get the Stockscreener App
0.4501
0.27%
0.0012
After Hours:
.47
0.0199
+4.42%
Immunoprecise Antibodies Ltd Stock (IPA) Forecast
The Immunoprecise Antibodies Ltd (IPA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.3733, representing a +1,094% increase from the current price of $0.4501. The highest analyst price target is $5.4647, and the lowest is $5.282.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IPA Price Target
Average 4.1804
(+828.77% Upside)
Is Immunoprecise Antibodies Ltd (IPA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.62 | Neutral |
| STOCH(9,6) | 52.43 | Neutral |
| STOCHRSI(14) | 4.0698 | Buy |
| MACD(12,26) | 0.0118 | Sell |
| ADX(14) | 14.39 | Neutral |
| William %R | -60.58 | Neutral |
| CCI(14) | 8.1448 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4561
Sell
|
0.4541
Sell
|
| MA20 |
0.4477
Buy
|
0.4453
Buy
|
| MA50 |
0.417
Buy
|
0.4336
Buy
|
| MA100 |
0.4398
Buy
|
0.4576
Sell
|
| MA200 |
0.5202
Sell
|
0.6193
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, IPA could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on IPA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 52.62 indicates that IPA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 52.43 indicates that IPA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.0698 indicates that IPA is oversold. This suggests that IPA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.39 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 8.1448 indicates that IPA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IPA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immunoprecise Antibodies Ltd financial reports and earnings history, Immunoprecise Antibodies Ltd (IPA) stock could reach $11.86 by 2030, $59.71 by 2040 and $25.66 by 2050. See the projected annual prices until 2050 of the Immunoprecise Antibodies Ltd stock below:
- Immunoprecise Antibodies Ltd (IPA) is expected to reach an average price of $8.3803 in 2035, with a high prediction of $9.3164 and a low estimate of $8.4543. This indicates an $1,762% rise from the last recorded price of $0.4501.
- Immunoprecise Antibodies Ltd (IPA) stock is projected to chart a bullish course in 2040, with an average price target of $57.35, representing an $12,643% surge from its current level. The forecast ranges from a conservative $58.12 to a sky-high $59.71.
- Our analysts predict Immunoprecise Antibodies Ltd (IPA) to jump 9,861% by 2045, soaring from $44.61 to an average price of $44.84, potentially reaching $45.79. While $44.61 is the low estimate, the potential upside is significant.
- Immunoprecise Antibodies Ltd (IPA) stock is expected to climb by 2050, reaching an average of $24.73, a $5,395% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.66 and $24.78, respectively, highlighting the market's uncertainty.
Immunoprecise Antibodies Ltd Stock (IPA) Year by Year Forecast
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2025
Immunoprecise Antibodies Ltd Stock (IPA) is expected to reach an average price of $5.0098 in 2025, with a high prediction of $5.9086 and a low estimate of $4.1111. This indicates an +1,013% rise from the last recorded price of $0.4501.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $5.2807 | $5.282 | $5.4647 | +1,073% |
| July, 2025 | $5.4639 | $4.958 | $5.1839 | +1,114% |
| August, 2025 | $6.7186 | $5.8512 | $5.9086 | +1,393% |
| September, 2025 | $4.8832 | $5.0232 | $5.7159 | +984.91% |
| October, 2025 | $4.6764 | $4.3205 | $3.9714 | +938.98% |
| November, 2025 | $3.7011 | $4.1111 | $4.4901 | +722.28% |
| December, 2025 | $5.2743 | $4.1597 | $4.9043 | +1,072% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2026
The predicted value for Immunoprecise Antibodies Ltd (IPA) in 2026 is set at an average of $3.3513. Estimates vary from a peak of $5.01 to a trough of $1.6927, indicating an +644.57% surge from the present price of $0.4501.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.799 | $4.979 | $5.01 | +966.20% |
| February, 2026 | $2.3436 | $3.4274 | $4.1463 | +420.68% |
| March, 2026 | $2.5682 | $2.4522 | $2.9396 | +470.59% |
| April, 2026 | $3.1815 | $3.4469 | $3.8542 | +606.84% |
| May, 2026 | $2.5961 | $2.6875 | $2.4675 | +476.78% |
| June, 2026 | $2.3502 | $2.5734 | $2.2548 | +422.16% |
| July, 2026 | $1.724 | $1.734 | $1.5315 | +283.03% |
| August, 2026 | $2.2086 | $1.6927 | $1.7586 | +390.70% |
| September, 2026 | $2.0219 | $2.2273 | $2.0173 | +349.21% |
| October, 2026 | $2.6965 | $2.2579 | $2.0365 | +499.09% |
| November, 2026 | $3.1911 | $3.1638 | $2.8938 | +608.98% |
| December, 2026 | $2.2744 | $2.6943 | $2.6871 | +405.31% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immunoprecise Antibodies Ltd (IPA) is $1.174, with a high forecast of $2.2181 and a low forecast of $0.1299. This indicates an +160.82% increase from the last price of $0.4501.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.039 | $2.2304 | $2.2181 | +353.02% |
| February, 2027 | $1.8037 | $1.965 | $1.7928 | +300.72% |
| March, 2027 | $2.1669 | $1.9123 | $1.8509 | +381.43% |
| April, 2027 | $2.2616 | $2.2542 | $2.1316 | +402.46% |
| May, 2027 | $1.8962 | $2.0889 | $1.9302 | +321.28% |
| June, 2027 | $1.6895 | $2.0148 | $2.1308 | +275.35% |
| July, 2027 | $1.8741 | $1.5781 | $1.6041 | +316.37% |
| August, 2027 | $1.8087 | $1.50 | $1.6527 | +301.84% |
| September, 2027 | $0.922 | $1.202 | $1.396 | +104.84% |
| October, 2027 | $0.4166 | $0.5066 | $0.8325 | -7.45% |
| November, 2027 | $0.1662 | $0.2612 | $0.3748 | -63.07% |
| December, 2027 | $0.1345 | $0.1299 | $0.5614 | -70.12% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2028
In 2028, Immunoprecise Antibodies Ltd (IPA) is projected to reach an average price of $10.15, with a high projection of $20.29 and a low estimate of $0.00358. This indicates an +2,154% rise from the last price of $0.4501.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0491 | $0.1818 | $0.0805 | -89.09% |
| February, 2028 | $15.63 | $0.00358 | $13.62 | +3,372% |
| March, 2028 | $13.49 | $15.24 | $13.77 | +2,898% |
| April, 2028 | $18.84 | $16.69 | $17.16 | +4,086% |
| May, 2028 | $18.18 | $18.03 | $18.35 | +3,939% |
| June, 2028 | $19.78 | $18.76 | $19.25 | +4,294% |
| July, 2028 | $20.00 | $19.77 | $19.89 | +4,343% |
| August, 2028 | $20.91 | $20.27 | $20.28 | +4,547% |
| September, 2028 | $18.57 | $19.34 | $20.29 | +4,027% |
| October, 2028 | $17.90 | $18.28 | $18.41 | +3,878% |
| November, 2028 | $18.40 | $18.02 | $17.88 | +3,988% |
| December, 2028 | $17.75 | $17.91 | $18.08 | +3,843% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2029
The 2029 price forecast for Immunoprecise Antibodies Ltd Stock (IPA) is $14.10 on average, with a high prediction of $17.31 and a low estimate of $10.88. This represents an +3,032% increase from the previous price of $0.4501.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.87 | $17.68 | $17.31 | +3,647% |
| February, 2029 | $16.94 | $17.36 | $16.97 | +3,665% |
| March, 2029 | $15.88 | $16.35 | $16.68 | +3,429% |
| April, 2029 | $15.87 | $15.82 | $16.00 | +3,427% |
| May, 2029 | $16.36 | $16.32 | $16.00 | +3,535% |
| June, 2029 | $15.15 | $16.33 | $16.27 | +3,266% |
| July, 2029 | $13.86 | $14.25 | $14.83 | +2,979% |
| August, 2029 | $13.70 | $14.14 | $14.14 | +2,945% |
| September, 2029 | $13.98 | $13.52 | $13.66 | +3,007% |
| October, 2029 | $13.92 | $13.99 | $14.01 | +2,993% |
| November, 2029 | $11.64 | $13.10 | $13.45 | +2,485% |
| December, 2029 | $11.31 | $10.88 | $11.23 | +2,413% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2030
Immunoprecise Antibodies Ltd Stock (IPA) is expected to reach an average price of $9.2465 in 2030, with a high forecast of $11.86 and a low forecast of $6.6346. This signifies an +1,954% surge from the last price of $0.4501.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.15 | $11.59 | $11.86 | +2,377% |
| February, 2030 | $10.32 | $10.33 | $10.78 | +2,194% |
| March, 2030 | $9.8591 | $10.01 | $9.9622 | +2,090% |
| April, 2030 | $9.2434 | $9.2161 | $9.4915 | +1,954% |
| May, 2030 | $8.6399 | $8.5553 | $8.2307 | +1,820% |
| June, 2030 | $8.6592 | $8.7692 | $8.5946 | +1,824% |
| July, 2030 | $8.2157 | $8.3357 | $8.3365 | +1,725% |
| August, 2030 | $8.725 | $8.843 | $8.7577 | +1,838% |
| September, 2030 | $8.3163 | $8.5142 | $8.1942 | +1,748% |
| October, 2030 | $7.1753 | $7.3808 | $7.5111 | +1,494% |
| November, 2030 | $6.77 | $6.83 | $6.8581 | +1,404% |
| December, 2030 | $6.5392 | $6.6346 | $6.4873 | +1,353% |
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):